← Eichor
Study identifier: NCT07096479 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor

Condition: Chemotherapy-induced Neutropenia  ·  Sponsor: Anhui Provincial Hospital

PhaseN/A
Planned participants318
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The objective of this real world study is to confirm the efficacy and saftey of Telpegfilgrastim injection for the prevention of chemotherapy-induced Neutropenia in Patients With Malignant solid tumor.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (2)

Anhui province hospitalHefei, Anhui, ChinaRecruiting
Anhui province hospitalHefei, Anhui, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07096479